key: cord-0268062-tpz93t0g
authors: Guo, Xiangyang; Steinkühler, Jan; Marin, Mariana; Li, Xiang; Lu, Wuyuan; Dimova, Rumiana; Melikyan, Gregory B.
title: Interferon-Induced Transmembrane Protein 3 Blocks Fusion of Diverse Enveloped Viruses by Locally Altering Mechanical Properties of Cell Membranes
date: 2020-06-26
journal: bioRxiv
DOI: 10.1101/2020.06.25.171280
sha: 6f76d1a1308cf70d4f59e4666ea6b85d82fd889b
doc_id: 268062
cord_uid: tpz93t0g

Interferon-induced transmembrane protein 3 (IFITM3) potently inhibits entry of diverse enveloped viruses by trapping the viral fusion at a hemifusion stage, but the underlying mechanism remains unclear. Here, we show that recombinant IFITM3 reconstituted into lipid vesicles induces negative membrane curvature and that this effect maps to its small amphipathic helix (AH). We demonstrate that AH: (i) partitions into lipid-disordered domains where IAV fusion occurs, (ii) induces negative membrane curvature, and (iii) increases lipid order and membrane stiffness. Additionally, replacing the IFITM3 AH with AH from an unrelated protein did not compromise its antiviral activity. These effects on membrane properties correlate with the fusion-inhibitory activity, as exogenous addition of AH to insulin-producing cells reduces glucose-stimulated insulin secretion. Our results thus imply that IFITM3 inhibits the transition from hemifusion to full fusion by imposing an unfavorable membrane curvature and increasing the order and stiffness of the cytoplasmic leaflet of endosomal membranes.

Introduction expressed and purified a fluorescently-tagged IFITM3 (referred to as IFITM3-iEGFP, 115 Figure S1C ). 125

We next tested the sidedness of IFITM3 incorporation based upon its accessibility to 126 proteolysis by trypsin. Addition of trypsin to IFITM3-or IFITM3-iEGFP-reconstituted 127 liposomes resulted in a nearly complete cleavage of both molecules, similar to cleavage 128 following proteoliposome solubilization in a detergent ( Figure S1D ). Thus, both 129 reconstituted proteins appear to insert into liposomes in a preferential orientation, with 130 their large cytoplasmic domains exposed to external medium. This result supports 131 biological membrane curvature is determined by an interplay between membrane phosphatidylethanolamine (PE), prefer negative membrane curvature, and inverted 230 cone-shaped lipids, like Lyso-PC (LPC), promote positive membrane curvature 231 (Kozlov, 2007) . 232

We therefore tested whether lipids play a role in IFITM3-mediated GUV vesiculation. 233

First, we electroformed POPC GUVs with or without cholesterol (0.5 mol%) and 234 treated these with IFITM3(1-108)-iEGFP. Whereas this treatment resulted in 75.5% of 235 cholesterol-containing GUVs with ILVs, a significant impairment of inward budding 236 (8.5% GUVs with ILVs) was observed in the absence of cholesterol ( Figure 3A , B). 237

Similarly, addition of the AH(56-71) peptide to GUVs without cholesterol also failed 238 to induce efficient inward budding ( Figure S3A Liss-Rho-PE ( Figure 4C ). The Scrambled AH(56-71) peptide also exhibited an Ld 277 phase preference, but failed to cause inward budding from this phase ( Figure 4C ). 278

Intriguingly, palmitoylation of Cys71 of a fluorescently-tagged AH(56-75) peptide did 279 not target this peptide to Lo phase. This peptide clearly partitioned to the Ld phase and 280 appeared to concentrate at the phase boundary ( Figure S4A ). 281

We then asked whether the full-length IFITM3 protein similarly localizes to the Ld 282 phase in cellular membranes. IFITM3 transits through the plasma membrane en route 283 to endolysosomal compartments and is thus present on the cell surface (Jia et al., 2014) . 284 with an internal SNAP-tag inserted at the same site as EGFP in IFITM3-iGFP (Suddala 287 et al., 2019) . SNAP-tagged IFITM3 was expressed in A549 cells and specifically 288 labeled with a fluorescent substrate SNAP-Cell 647-SiR. Next, membrane spheres 289 derived from the plasma membrane were obtained by cell swelling and phase separation 290 within these spheres was induced by crosslinking a lipid raft marker GM1 with a labeled 291 cholera toxin B subunit (Lingwood et al., 2008) ( Figure 4D ). The IFITM3-iSNAP 292 partitioned to the Ld phase of membrane spheres, suggesting that the full-length 293 IFITM3 is also localized to non-raft domains in living cells ( Figure 4D ). 294

Next, we sought to test whether the IFITM3 localization to Ld phase may be augment 295 for its antiviral activity. To answer this question, we employed a lipid mixing assay 296 between IAV labeled with a self-quenching concentration of the lipophilic dye DiD and 297

GUVs. Here, addition of labeled IAV to GUVs followed by acidification should trigger 298 lipid mixing which can be detected by the appearance of dequenched DiD in the GUV 299 membrane ( Figure 4E ). Using phase-separated GUVs, we found that, upon triggering 300 IAV-GUV fusion by exposure to low pH, DiD accumulated within the Ld domain 301 ( Figure S4B ), although in the presence of IAV receptor ganglioside GM1, which 302 dominantly accumulates in Lo domain ( Figure S4C ), suggesting that IAV lipid mixing 303 occurred in a non-raft phase ( Figure S4C ). To test the possibility of DiD redistribution 304 between Lo and Ld phases after viral fusion, single-phase GUVs were prepared. Low 305 pH-induced IAV lipid mixing occurred very efficiently with Ld-phase GUVs ( Figure  306 4F), whereas no lipid mixing was detected between IAV and Lo-phase GUVs, in spite 307 of the efficient binding of labeled viruses to these vesicles ( Figure 4F ). Taken together, 308 these results imply that IFITM3 concentrates in non-raft domains which appear to be 309 the sites supporting IAV fusion in synthetic membranes. 310

Since IFITM3 tends to localize to non-raft microdomains of membranes and induces 312 negative curvature through its AH, we asked whether this helical domain affects other 313 membrane properties, such as lipid order and membrane stiffness. Lipid order, which 314 an environment-sensitive dye that intercalates between the hydrocarbon tails of lipids 317 and exhibits a red-shift in the emission spectrum upon exposure to polar solvent, i.e., 318

in lipid disordered domains. The Laurdan emission shift is parameterized by 319 generalized polarization (GP), which is a normalized difference between Laurdan's 320 peptide on GP is likely due to its higher binding affinity to membranes ( Figure 5B ). 327

These findings imply that IFITM3 AH specifically increases the lipid order. 

The ability of IFITM3 AH to induce negative curvature, increase the lipid order and 340 stiffen the membrane implies that region is responsible for the protein's inhibitory 341 effect on viral fusion. We hypothesized that AH interaction with the cytoplasmic leaflet 342 of endosomal membranes is necessary and sufficient for the antiviral activity IFITM3. 343

However, testing this hypothesis in vitro using reconstituted IFITM3 peptides is not 344 cytoplasmic region of IFITM3 that encompasses the AH, whereas reconstituted 346 IFITM3 and IFITM3 AH localize to the external leaflet of endosomes ( Figure 1A It is worth pointing out that AH is present in IFITM1 and IFITM2 proteins and is highly 453 and kept under vacuum for 1 hr. Electroformation chambers were constructed by 590 sandwiching a 1 mm spacer between two lipid-coated slides. Next, the chamber was 591 filled with 0.1 M sucrose, 1 mM HEPES, pH 7.0, and a 10 Hz sine wave voltage (1 V 592 dissolved in 50 l chloroform/methanol (9:1) in a glass tube and placed in a preheated 597 block at 60 °C for 1 min after gentle vortexing and centrifugation. The mixture was 598 then immediately deposited and spread over 2 preheated ITO coverslips, and the solvent 599 was evaporated at 60 °C. After ITO coverslips dried out, they were immediately placed 600 into a vacuum chamber for 1h to remove residual solvent. All these steps were done in 601 a timely manner to minimize possible lipid oxidation. GUV electroformation was 602 carried out in 0.1 M sucrose, 2 mM DTT, 1 mM HEPES, pH 7.0 at 60 °C for 4 h. 603

Collected GUVs were cooled to room temperature and used immediately. and imaged at room temperature on a Zeiss LSM880 laser scanning confocal 636 microscopes, using a 63x/1.4NA oil-immersion objective. 637

Virus labeling was performed essentially as described previously (Suddala et al., 2019) . 

Negative Imprinting of Virion Particle Infectivity and in Target Cell 778

Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1

Ifitm3 limits the severity 781 of acute influenza in mice

Interferon-induced 784 transmembrane protein 3 is a type II transmembrane protein

The 2018 biomembrane curvature and remodeling 788 roadmap

The IFITM proteins mediate cellular resistance to 791 influenza A H1N1 virus, West Nile virus, and dengue virus

High-throughput luminescent reporter of insulin

Biomembrane 811 fusion: a new concept derived from model studies using two interacting planar 812 lipid bilayers

IFITM3 requires an amphipathic helix 815 for antiviral activity

IFITM3 restricts influenza A virus entry by blocking the formation of 819 fusion pores following virus-endosome hemifusion

The broad-spectrum antiviral functions of IFIT 822 and IFITM proteins

Amphipathic helices and membrane curvature

Defining the range of pathogens susceptible to Ifitm3

Order of lipid phases in model and plasma 874 membranes

Asymmetric Ionic Conditions Generate Large Membrane Curvatures

Determination of lipid spontaneous curvature from X-ray 880 examinations of inverted hexagonal phases

Stalk mechanism of vesicle fusion. Intermixing of aqueous 884 contents

Palmitoylation regulates raft affinity for the majority of integral raft proteins

Proceedings of the National Academy of Sciences of the United States of 888

Membrane remodeling by the M2 amphipathic helix 905 drives influenza virus membrane scission

Membrane curvature and mechanisms of 909 dynamic cell membrane remodelling

Glucose sensitivity and metabolism-secretion coupling studied during 913 two-year continuous culture in INS-1E insulinoma cells

IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift 917

Valley fever virus

Phase Fluctuation in 919

Steric confinement of 932 proteins on lipid membranes can drive curvature and tubulation

Controlled division of cell-sized vesicles by low 937 densities of membrane-bound proteins

Mechanical properties of plasma membrane vesicles correlate with lipid order, 941 viscosity and cell density

Effect of membrane curvature-modifying lipids on 944 membrane fusion by tick-borne encephalitis virus

Interferon-induced transmembrane protein 3 948 blocks fusion of sensitive but not resistant viruses by partitioning into virus-949 carrying endosomes

Interference with the production of infectious 953 unilamellar vesicles -a perfect tool to visualize phase separation and lipid 966 rafts in model systems

IFITM Proteins Inhibit Entry 969 Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-970

Site-Specific Photo-Crosslinking Proteomics Reveal Regulation of IFITM3

Trafficking and Turnover by VCP/p97 ATPase

HIV virions sense plasma membrane 977 heterogeneity for cell entry

Palmitoylome profiling reveals S-palmitoylation-981 dependent antiviral activity of IFITM3

Interferon-induced transmembrane protein-3 genetic variant rs12252-985 cholesterol and counteracted by lyso-lipids. (A) GUVs with cholesterol

1036 108)-iEGFP for 30 min and imaged. Scale bars 20 μm. (B) Quantification of inward 1037 budding shows the percentage of GUVs prepared and

Data represent mean ± SD of the results of 1039 three independent experiments, with at least 90 GUVs analyzed per sample in each 1040 experiment. (C) GUVs (99.0 mol % POPC, 0.5 mol % cholesterol

56-71) and 10 μM LPC dissolved in methanol 1042 (+LPC) or the same volume of methanol (-LPC) for 30 min and imaged. Fluorescein 1043 (0.3 μM) was added to mark inward budding of GUVs

Quantification of inward budding showing the percentage of GUVs prepared and 1045 treated as in (C), with at least one fluorescein-containing intraluminal vesicle (ILV)

Data represent mean ± SD of three independent experiments, with at least 35 GUVs 1047 analyzed per sample in each experiment

illustrating glucose-stimulated insulin secretion and its block by IFITM3 AH

IFITM3 AH peptide inhibited glucose-stimulated insulin secretion of INS-1E cells

59-68) or 10 μM AH(59-68) F63Q or same volume of DMSO 1092 (mock) and then stimulated for 20 min with high glucose (HG, 20 mM) buffer or with 1093 low glucose (LG, 2.8 mM) as control

Data represent mean ± SD of the results of three independent experiments. The 1096 statistical analysis used is the Student's t-test. (C) As in (B), but for samples 1097 preincubated for 5 min with AH peptide or DMSO supplemented with 20 µM LPC

GUVs (bottom, 66.6 mol % SM, 30.9 mol % cholesterol, 2% GM1, 0.5 mol % 1064TopFluor-cholesterol) were mixed with DiD labeled IAV, lipids mixing was triggered 1065by addition of citrate buffer to achieve the final pH of 5.0, and samples immediately 1066imaged. Scale bars 5 μm. See also Figure S4 . 1067 IAV at a "dead-end" hemifusion stage. See also Figure S5 .